ENTASIS THERAPEUTICS HLDGS I's ticker is ETTX and the CUSIP is 293614103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $99,000 | -38.5% | 52,797 | -28.3% | 0.00% | -100.0% |
| Q4 2021 | $161,000 | -29.7% | 73,597 | +7.3% | 0.00% | 0.0% |
| Q3 2021 | $229,000 | +23.1% | 68,597 | -1.3% | 0.00% | 0.0% |
| Q2 2021 | $186,000 | +22.4% | 69,487 | -2.0% | 0.00% | 0.0% |
| Q1 2021 | $152,000 | -1.9% | 70,930 | +13.2% | 0.00% | 0.0% |
| Q4 2020 | $155,000 | +44.9% | 62,663 | +20.0% | 0.00% | 0.0% |
| Q3 2020 | $107,000 | -34.0% | 52,238 | -4.8% | 0.00% | 0.0% |
| Q2 2020 | $162,000 | +19.1% | 54,898 | +6.5% | 0.00% | 0.0% |
| Q1 2020 | $136,000 | -43.1% | 51,555 | +7.1% | 0.00% | -50.0% |
| Q4 2019 | $239,000 | -14.3% | 48,155 | +2.8% | 0.00% | 0.0% |
| Q3 2019 | $279,000 | -3.8% | 46,861 | +4.3% | 0.00% | 0.0% |
| Q2 2019 | $290,000 | +0.3% | 44,917 | +5.0% | 0.00% | 0.0% |
| Q1 2019 | $289,000 | +71.0% | 42,792 | +3.2% | 0.00% | 0.0% |
| Q4 2018 | $169,000 | – | 41,469 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GARDNER LEWIS ASSET MANAGEMENT L P | 1,249,778 | $2,750,000 | 0.55% |
| Beryl Capital Management LLC | 1,131,772 | $2,490,000 | 0.26% |
| DELTEC ASSET MANAGEMENT LLC | 155,614 | $342,000 | 0.08% |
| Knott David M Jr | 41,700 | $92,000 | 0.04% |
| TPG GP A, LLC | 1,020,748 | $2,246,000 | 0.04% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 40,900 | $90,000 | 0.01% |
| Ergoteles LLC | 135,323 | $298,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 132,600 | $292,000 | 0.01% |
| Virtu Financial LLC | 20,027 | $44,000 | 0.00% |
| GABELLI FUNDS LLC | 59,100 | $130,000 | 0.00% |